Top Page
Peoplein Limited
(Sydney:PPE)
Peoplein Limited (PPE) vs. iShares MSCI Australia ETF (EWA)
Peoplein Limited Business Overview & Revenue Model
Peoplein Limited Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.10B | 1.10B | 1.17B | 1.18B | 679.17M | 429.69M |
| Gross Profit | 550.73M | 1.08B | 71.24M | 86.32M | 63.37M | 33.75M |
| EBITDA | 18.20M | 13.58M | 32.84M | 52.64M | 39.74M | 35.04M |
| Net Income | -12.76M | -12.76M | 4.67M | 18.94M | 17.67M | 17.66M |
Balance Sheet | ||||||
| Total Assets | 348.58M | 348.58M | 391.28M | 417.57M | 377.54M | 223.86M |
| Cash, Cash Equivalents and Short-Term Investments | 32.83M | 32.83M | 37.29M | 39.87M | 26.98M | 13.72M |
| Total Debt | 112.15M | 112.15M | 141.37M | 113.06M | 111.54M | 46.97M |
| Total Liabilities | 197.08M | 197.08M | 231.25M | 257.57M | 235.18M | 109.26M |
| Stockholders Equity | 147.59M | 147.59M | 156.57M | 156.59M | 139.76M | 112.23M |
Cash Flow | ||||||
| Free Cash Flow | 33.19M | 33.19M | -9.86M | 55.42M | 17.71M | 6.28M |
| Operating Cash Flow | 34.87M | 34.87M | -3.58M | 64.52M | 22.20M | 7.58M |
| Investing Cash Flow | -5.75M | -5.75M | -14.99M | -21.26M | -54.48M | -23.29M |
| Financing Cash Flow | -33.77M | -33.77M | 15.91M | -30.50M | 45.55M | -2.06M |
Peoplein Limited Technical Analysis
Peoplein Limited Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | AU$70.22M | 11.00 | 60.81% | 6.25% | 6.72% | 5.68% | |
68 Neutral | AU$35.03M | 15.89 | 7.05% | 5.20% | -7.29% | 60.64% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
52 Neutral | AU$77.16M | -5.84 | -8.39% | ― | -6.45% | -364.91% | |
43 Neutral | AU$11.80M | -0.67 | ― | ― | 14.07% | -157.40% | |
38 Underperform | AU$8.62M | -5.06 | -215.06% | ― | -0.80% | -6.58% |
Peoplein Limited Corporate Events
Peoplein Limited has applied to the ASX for quotation of 176,623 new fully paid ordinary shares, issued on 6 January 2026, under its ticker PPE. The additional securities arise from the exercise or conversion of existing options or other convertible securities, modestly increasing the company’s quoted share capital and potentially enhancing liquidity for investors without indicating any broader strategic shift in operations.
The most recent analyst rating on (AU:PPE) stock is a Buy with a A$1.20 price target. To see the full list of analyst forecasts on Peoplein Limited stock, see the AU:PPE Stock Forecast page.
PeopleIN Limited has completed the divestment of its First Choice Care health and aged care staffing business and Edmen youth and disability staffing business to Healthcare Australia Pty Ltd. The move streamlines PeopleIN’s portfolio while it continues to focus on its broader multi-sector workforce solutions footprint, though the company will now have reduced direct exposure to certain health, aged care, youth and disability staffing market segments.
The most recent analyst rating on (AU:PPE) stock is a Buy with a A$1.10 price target. To see the full list of analyst forecasts on Peoplein Limited stock, see the AU:PPE Stock Forecast page.
Peoplein Limited has announced the sale of its Health and Community brands, FCC and Edmen, to Healthcare Australia (HCA). This strategic divestment, conducted at a strong multiple of 6.2x, enables the company to strengthen its focus on growth sectors, including infrastructure construction in Queensland, defense, food services, agriculture, and professional services, while ensuring the future growth and opportunities for its workforce.
The most recent analyst rating on (AU:PPE) stock is a Buy with a A$1.30 price target. To see the full list of analyst forecasts on Peoplein Limited stock, see the AU:PPE Stock Forecast page.
PeopleIN Limited has announced the divestment of its health and aged care staffing business, First Choice Care, and Youth and Disability staffing business, Edmen, for $20.25 million to Healthcare Australia (HCA). This strategic move will eliminate the company’s net debt and reallocate capital toward growth-focused sectors such as Defence, Engineering, and Labour, while expanding into international staffing platforms. The transaction aims to enhance PeopleIN’s long-term value and shareholder returns, positioning it for sustainable growth and market leadership.
The most recent analyst rating on (AU:PPE) stock is a Buy with a A$1.30 price target. To see the full list of analyst forecasts on Peoplein Limited stock, see the AU:PPE Stock Forecast page.
Peoplein Limited has announced a trading halt on its securities pending the release of a significant update about their operations concerning a material divestment transaction. The temporary suspension is expected to ensure orderly trading and transparency, with potential implications for the company’s operational strategy and stakeholder interests.
The most recent analyst rating on (AU:PPE) stock is a Buy with a A$1.30 price target. To see the full list of analyst forecasts on Peoplein Limited stock, see the AU:PPE Stock Forecast page.
PeopleIN Limited has announced a change in the interests of its director, Thomas William Reardon, who has acquired 272,727 unquoted performance rights. These rights are to be converted into PPE shares under the 2024 Performance Rights Plan, following shareholder approval at the recent Annual General Meeting. This development signifies a strategic move for PeopleIN Limited, potentially impacting its market positioning and shareholder value.
The most recent analyst rating on (AU:PPE) stock is a Buy with a A$1.30 price target. To see the full list of analyst forecasts on Peoplein Limited stock, see the AU:PPE Stock Forecast page.
Peoplein Limited has announced the cessation of 71,094 performance rights due to the conditions for these securities not being met or becoming incapable of being satisfied. This announcement may impact the company’s capital structure and could have implications for stakeholders, reflecting on the company’s operational adjustments or strategic decisions.
The most recent analyst rating on (AU:PPE) stock is a Buy with a A$1.30 price target. To see the full list of analyst forecasts on Peoplein Limited stock, see the AU:PPE Stock Forecast page.
PeopleIN Limited has issued a correction to the Appendix 3Y for Director Thomas Reardon, initially lodged on December 8, 2025. The corrected document reflects the accurate number of shares held by Reardon before and after the change, with the figures adjusted to 5,111,156 and 5,283,570 shares, respectively. This update ensures accurate reporting of director interests, which is crucial for maintaining transparency and compliance with ASX regulations.
The most recent analyst rating on (AU:PPE) stock is a Buy with a A$1.30 price target. To see the full list of analyst forecasts on Peoplein Limited stock, see the AU:PPE Stock Forecast page.
PeopleIn Limited announced a change in the director’s interest, with Thomas William Reardon acquiring 172,414 fully paid ordinary shares following the vesting of performance rights under the company’s Performance Rights Plan. This adjustment increases Reardon’s total holdings to 5,123,570 shares, reflecting the company’s ongoing commitment to aligning executive interests with shareholder value and potentially impacting investor perceptions positively.
The most recent analyst rating on (AU:PPE) stock is a Buy with a A$1.30 price target. To see the full list of analyst forecasts on Peoplein Limited stock, see the AU:PPE Stock Forecast page.
Peoplein Limited has announced a new issuance of 172,414 fully paid ordinary securities, which are set to be quoted on the Australian Securities Exchange (ASX) under the code PPE. This move indicates an expansion in the company’s capital base, potentially enhancing its financial flexibility and market presence.
The most recent analyst rating on (AU:PPE) stock is a Buy with a A$1.30 price target. To see the full list of analyst forecasts on Peoplein Limited stock, see the AU:PPE Stock Forecast page.
PeopleIN Limited has completed the divestment of its 79.3% stake in Techforce Personnel Pty Ltd. This strategic move may impact the company’s operations and industry positioning by allowing PeopleIN to potentially refocus resources on its core sectors, enhancing its service offerings and market presence in the workforce solutions industry.
The most recent analyst rating on (AU:PPE) stock is a Buy with a A$1.30 price target. To see the full list of analyst forecasts on Peoplein Limited stock, see the AU:PPE Stock Forecast page.
Peoplein Limited has announced the issuance of 937,753 performance rights as part of an employee incentive scheme, which are not intended to be quoted on the ASX. This move reflects the company’s strategy to motivate and retain talent, potentially enhancing its operational capabilities and competitive positioning in the market.
The most recent analyst rating on (AU:PPE) stock is a Buy with a A$1.19 price target. To see the full list of analyst forecasts on Peoplein Limited stock, see the AU:PPE Stock Forecast page.
Peoplein Limited held its Annual General Meeting on November 27, 2025, where several key resolutions were voted on. The re-election of directors Vu Tran and Thomas Reardon was approved, along with the remuneration report and the grant of performance rights to Managing Director Ross Thompson and Executive Director Thomas Reardon. These approvals indicate strong shareholder support for the company’s leadership and compensation strategies, which could positively impact the company’s governance and operational stability.
The most recent analyst rating on (AU:PPE) stock is a Buy with a A$1.45 price target. To see the full list of analyst forecasts on Peoplein Limited stock, see the AU:PPE Stock Forecast page.
In a challenging year for the staffing industry, PeopleIN Limited managed to outperform its peers by strengthening its balance sheet through strong cash collections and debt reduction, despite a decline in revenue and EBITDA. The company announced a $6 million share buy-back to enhance shareholder value and is well-positioned to capitalize on future growth opportunities in Queensland’s infrastructure cycle and the Defence sector. PeopleIN also entered into an agreement to sell its stake in Techforce Personnel Pty Ltd, reflecting its active capital management strategy.
The most recent analyst rating on (AU:PPE) stock is a Buy with a A$1.45 price target. To see the full list of analyst forecasts on Peoplein Limited stock, see the AU:PPE Stock Forecast page.
PeopleIN Limited has announced the divestment of its 79.3% stake in Techforce Personnel Pty Ltd for $23.5 million, achieving a return of over 100% on its investment over four years. This strategic move is expected to strengthen PeopleIN’s financial position, reducing net debt and enabling the company to pursue further acquisitions, thereby accelerating its growth strategy to become the largest workforce solutions provider in Australia.
The most recent analyst rating on (AU:PPE) stock is a Buy with a A$1.45 price target. To see the full list of analyst forecasts on Peoplein Limited stock, see the AU:PPE Stock Forecast page.
Peoplein Limited has announced an update regarding its ongoing buy-back program. The company reported the buy-back of 26,971 ordinary fully paid securities on the previous day, bringing the total number of securities bought back to 2,008,325. This buy-back initiative is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (AU:PPE) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Peoplein Limited stock, see the AU:PPE Stock Forecast page.
Peoplein Limited has announced an update regarding its ongoing on-market buy-back program, with a total of 1,874,287 securities bought back before the previous day and an additional 134,038 securities acquired on the previous day. This buy-back initiative is part of the company’s strategy to optimize its capital structure and potentially enhance shareholder value, reflecting its commitment to maintaining a robust market position.
The most recent analyst rating on (AU:PPE) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Peoplein Limited stock, see the AU:PPE Stock Forecast page.
Peoplein Limited has announced an update regarding its ongoing buy-back program, which involves the repurchase of its ordinary fully paid securities listed under the ASX code PPE. The company has bought back a total of 1,714,499 securities before the previous day, with an additional 69,338 securities repurchased on the previous day. This buy-back initiative is part of Peoplein Limited’s strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (AU:PPE) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Peoplein Limited stock, see the AU:PPE Stock Forecast page.
Peoplein Limited has announced an update regarding its ongoing share buy-back program. The company reported that it has bought back a total of 1,624,257 ordinary fully paid securities before the previous day and an additional 90,242 securities on the previous day. This buy-back initiative is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (AU:PPE) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Peoplein Limited stock, see the AU:PPE Stock Forecast page.
Peoplein Limited has announced an update regarding its ongoing on-market buy-back program. The company reported that a total of 1,522,396 securities had been bought back before the previous day, with an additional 15,681 securities repurchased on the previous day. This buy-back initiative reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (AU:PPE) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Peoplein Limited stock, see the AU:PPE Stock Forecast page.